Actively Recruiting

Phase Not Applicable
Age: 10Years - 16Years
All Genders
NCT05558566

Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

Led by Yale University · Updated on 2025-08-06

64

Participants Needed

1

Research Sites

220 weeks

Total Duration

On this page

Sponsors

Y

Yale University

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is a clinical trial where adolescents aged 10-16 years old with Tourette Syndrome (or chronic tic disorder) are randomized to receive either real-time functional magnetic resonance imaging (fMRI) neurofeedback targeting the supplementary motor area (for the experimental intervention) or real-time fMRI neurofeedback (NF) from a control region (for the control intervention).

CONDITIONS

Official Title

Neurofeedback From the Supplementary Motor Area for Tourette Syndrome

Who Can Participate

Age: 10Years - 16Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Boys and girls, 10 to 16 years of age
  • Current diagnosis of Tourette Syndrome or chronic tic disorder with active tics executable without head movement
  • YGTSS score of at least 13 for Tourette Syndrome or at least 12 for chronic tic disorder
  • Currently stable medication treatment with no planned changes during the study
  • Family residence within 2 hours of Yale Medical Center and willingness to attend visits
  • Ability of child and parents to speak and understand spoken English
  • No metal medical implants or braces
  • Not pregnant
  • Body weight less than 250 lbs
  • No claustrophobia
Not Eligible

You will not qualify if you...

  • Intelligence quotient below 80
  • Current diagnosis of autism spectrum disorder, bipolar or psychotic disorder, or current suicidality
  • Significant medical conditions such as heart disease, hypertension, liver or renal failure, pulmonary disease, or seizure disorder
  • Psychotherapy initiated less than 8 weeks ago; ongoing psychotherapy started at least 8 weeks ago is allowed but no new psychotherapy during the study
  • Exclusion if unable to localize target brain regions during first MR scan

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Yale University School of Medicine

New Haven, Connecticut, United States, 06520

Actively Recruiting

Loading map...

Research Team

C

Cheyenne Harris-Starling

CONTACT

J

Jitendra Awasti

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here